Inventor · disambiguated record
Juerg Lehmann
Also filed as: LEHMANN JUERG
19 granted patents·20 pending applications·238 citations·filing 2004–2024
95Inventor score
Top patents by PatentIndex Score
39 records- 0196US7884101B23-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2006·Granted Feb 8, 2011·42 cites·2 claims
- 0294US8580841B2Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disordersJONES ROBERT M·Filed 2009·Granted Nov 12, 2013·21 cites·51 claims
- 0394US8415484B2Substituted tricyclic acid derivatives as S1P1 receptor agonists useful in the treatment of autoimmune and inflammatory disordersJONES ROBERT M·Filed 2009·Granted Apr 9, 2013·29 cites·48 claims
- 0494US7838525B2Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related theretoARENA PHARM INC·Filed 2006·Granted Nov 23, 2010·39 cites·69 claims
- 0593US9126932B2Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disordersARENA PHARM INC·Filed 2013·Granted Sep 8, 2015·17 cites·61 claims
- 0692US9522133B2Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disordersARENA PHARM INC·Filed 2015·Granted Dec 20, 2016·9 cites·42 claims
- 0791US7470699B2Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related theretoARENA PHARM INC·Filed 2004·Granted Dec 30, 2008·41 cites·57 claims
- 0890US8785441B23-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related theretoTEEGARDEN BRADLEY·Filed 2012·Granted Jul 22, 2014·11 cites·16 claims
- 0989US8362248B2Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related theretoARENA PHARM INC·Filed 2006·Granted Jan 29, 2013·10 cites·1 claims
- 1089US2025074874A1SUBSTITUTED (1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERSARENA PHARM INC·Filed 2024·Application pending·0 cites
- 1185US9108969B2Substituted tricyclic acid derivatives as S1P1 receptor agonists useful in the treatment of autoimmune and inflammatory disordersARENA PHARM INC·Filed 2013·Granted Aug 18, 2015·6 cites·33 claims
- 1282US7816364B2GRP119 receptor agonists in methods of increasing bone mass and of treating osteoporosis and other conditions characterized by low bone mass, and combination therapy relating theretoARENA PHARM INC·Filed 2007·Granted Oct 19, 2010·4 cites·171 claims
- 1381US10624900B25-HT2C receptor agonists and compositions and methods of useARENA PHARM INC·Filed 2019·Granted Apr 21, 2020·1 cites·25 claims
- 1481US2023257349A1SUBSTITUTED (1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERSARENA PHARM INC·Filed 2022·Application pending·0 cites
- 1580US10272094B25-HT2C receptor agonists and compositions and methods of useARENA PHARM INC·Filed 2016·Granted Apr 30, 2019·1 cites·49 claims
- 1680US8101626B2GPR119 receptor agonists in methods of increasing bone mass and of treating osteoporosis and other conditions characterized by low bone mass, and combination therapy relating theretoCHU ZHI-LIANG·Filed 2010·Granted Jan 24, 2012·4 cites·38 claims
- 1776US2023055376A15-ht2c receptor agonists and compositions and methods of useARENA PHARM INC·Filed 2022·Application pending·0 cites
- 1875US9676758B21-heteroaryl-indoline-4-carboxamides as modulators of GPR52 useful for the treatment or prevention of disorders related theretoARENA PHARM INC·Filed 2016·Granted Jun 13, 2017·3 cites·41 claims
- 1972US2020407316A1SUBSTITUTED (1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERSARENA PHARM INC·Filed 2020·Application pending·0 cites
- 2068US10781180B23-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2018·Granted Sep 22, 2020·0 cites·39 claims
- 2167US2019135752A1SUBSTITUTED (1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERSARENA PHARM INC·Filed 2018·Application pending·0 cites
- 2266US11395824B25-HT2C receptor agonists and compositions and methods of useARENA PHARM INC·Filed 2020·Granted Jul 26, 2022·0 cites·6 claims
- 2362US2017217885A1SUBSTITUTED 1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERSARENA PHARM INC·Filed 2016·Application pending·0 cites
- 2459US2007244086A13-Phenyl-Pyrazole Derivatives as Modulators of the 5-Ht2A Serotonin Receptor Useful for the Treatment of Disorders Related TheretoARENA PHARM INC·Filed 2005·Application pending·0 cites
- 2559US2021340133A1Modulators of the gpr119 receptor and the treatment of disorders related theretoARENA PHARM INC·Filed 2020·Application pending·0 cites
- 2658US2016304463A13-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2016·Application pending·0 cites
- 2757US10894787B2Modulators of the GPR119 receptor and the treatment of disorders related theretoJONES ROBERT M·Filed 2011·Granted Jan 19, 2021·0 cites·35 claims
- 2857US2007078150A1Substituted pyrindinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related theretoARENA PHARM INC·Filed 2006·Application pending·0 cites
- 2956US2011105456A13-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related theretoTEEGARDEN BRADLEY·Filed 2010·Application pending·0 cites
- 3055US2006155128A1Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related theretoJONES ROBERT M·Filed 2006·Application pending·0 cites
- 3150US8546429B21,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related theretoJONES ROBERT M·Filed 2010·Granted Oct 1, 2013·0 cites·29 claims
- 3248US2014066369A1Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related TheretoJONES ROBERT M·Filed 2012·Application pending·0 cites
- 3348US2015336966A1Substituted tricyclic acid derivatives as s1p1 receptor agonists useful in the treatment of autoimmune and inflammatory disordersARENA PHARM INC·Filed 2015·Application pending·0 cites
- 3447US2010004272A1Modulators of metabolism and the treatment of disorders related theretoARENA PHARM INC·Filed 2007·Application pending·0 cites
- 3547US2009286816A1Modulators of metabolism and the treatment of disorders related theretoARENA PHARM INC·Filed 2007·Application pending·0 cites
- 3645US2010160359A1Modulators of Metabolism and the Treatment of Disorders Related TheretoARENA PHARM INC·Filed 2006·Application pending·0 cites
- 3742US2009036434A1Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related theretoARENA PHARM INC·Filed 2005·Application pending·0 cites
- 3842US2014018371A1Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related TheretoJONES ROBERT M·Filed 2012·Application pending·0 cites
- 3938US2013023494A1Modulators of the gpr119 receptor and the treatment of disorders related theretoARENA PHARM INC·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Juerg Lehmann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →